Pfizer – Global Health Press

GHP News Infographic

Global vaccine production – Estimated key figures (2025-2026)

Download Infographic Overview Global vaccine production is estimated at approximately 14.5 billion doses annually. The global vaccine market reached around $35 billion in revenue in 2024–2025. Major global players...

9 April, 2026

1 min read

GHP News Infographic

mRNA vaccines: from sequence to shot

Download Infographic Overview The concept of mRNA as a vaccine platform has evolved over several decades, using host cells to produce antigens. mRNA vaccines can induce both B cell and T cell immune responses and avoid...

25 March, 2026

1 min read

GHP News Latest Science

Clostridioides difficile vaccines: one step back, two steps forward

After years of disappointments, the C. difficile vaccine field is quietly repositioning itself. While GSK has officially dropped its own toxoid candidate from the pipeline, at least two other toxin‑based approaches—one...

25 March, 2026

5 min read

GHP News Latest Science

Status of Group B Streptococcus (GBS) for Vaccination in Pregnancy (ViP)

We are aware of two vaccines in late clinical development (Phase 2 completed) globally to address a significant medical need for pregnant women and their offspring, one from Pfizer in the United States and one from...

18 December, 2025

4 min read

Africa Asia GHP News Outbreak Countries

November 2025 vaccine – manufacturer news

Western Companies Pfizer updated its public R&D pipeline on 4 November 2025, highlighting late-stage vaccine assets (including RSV, meningococcal, and next-generation COVID products) while signaling a more selective...

3 December, 2025

3 min read

GHP News Latest Science

Global vaccine industry update: Key developments (2025–2026)

Western Companies Moderna announced topline results from a Phase 3 pivotal trial evaluating mRNA-1647, an investigational cytomegalovirus (CMV) vaccine. The study did not meet its primary efficacy endpoint of preventing...

29 October, 2025

2 min read

GHP News Latest Science

Vaccine manufacturer news – October 19, 2025

October 18 2025 – Pfizer Inc. reported strong global engagement ahead of IDWeek 2025 in Atlanta, where the company presented findings from 46 clinical and real-world vaccine studies covering COVID-19, RSV, pneumococcal...

21 October, 2025

5 min read

GHP News Latest Science

Vaccine manufacturers
update week 34

1. Pfizer (USA) and BioNTech (Germany) News: Pfizer and BioNTech have submitted a new application to the European Medicines Agency for a COVID-19 vaccine adapted to the 2025–2026 LP.8.1 strain. Pfizer and BioNTech...

19 August, 2025

2 min read

Latest Science

Pfizer’s TICOVAC vaccine gets US FDA approval for active immunization to prevent tick-borne encephalitis

Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved TICOVAC (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older. TICOVAC is...

16 August, 2021

3 min read

Latest Science

Pfizer, BioNTech COVID-19 vaccine planned for late November FDA submission

The first coronavirus 2019 (COVID-19) vaccine to be considered for emergency approval may be a month away. Pfizer chief executive officer Albert Bourla wrote in an open letter Friday morning that efficacy and safety...

20 October, 2020

3 min read

Tag - Pfizer